StockNews.com started coverage on shares of Veradigm (NASDAQ:MDRX – Free Report) in a research report report published on Friday morning. The firm issued a hold rating on the software maker’s stock.
Veradigm Trading Up 1.5 %
Veradigm stock opened at $9.40 on Friday. The company has a 50 day moving average of $9.51 and a 200-day moving average of $9.19. Veradigm has a twelve month low of $5.01 and a twelve month high of $13.51.
Institutional Investors Weigh In On Veradigm
Several institutional investors have recently bought and sold shares of the company. Vanguard Group Inc. increased its position in shares of Veradigm by 0.7% during the 4th quarter. Vanguard Group Inc. now owns 14,275,875 shares of the software maker’s stock worth $149,754,000 after purchasing an additional 95,291 shares during the last quarter. Tyro Capital Management LLC acquired a new stake in Veradigm during the 1st quarter valued at $9,055,000. Finally, Innealta Capital LLC bought a new stake in shares of Veradigm during the 2nd quarter worth about $38,000.
Veradigm Company Profile
Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.
Further Reading
- Five stocks we like better than Veradigm
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- Intel: Is Now the Time to Be Brave?
- What is the Hang Seng index?
- Carnival or Royal Caribbean—Which Cruise Stock Has More Upside?
- What Are Some of the Best Large-Cap Stocks to Buy?
- Summit Therapeutics: Is Their Lung Cancer Drug a Game Changer?
Receive News & Ratings for Veradigm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veradigm and related companies with MarketBeat.com's FREE daily email newsletter.
